J Christopher States Selected Research

sodium arsenite (sodium metaarsenite)

1/2021	Dynamic alteration in miRNA and mRNA expression profiles at different stages of chronic arsenic exposure-induced carcinogenesis in a human cell culture model of skin cancer.
5/2014	Cisplatin plus sodium arsenite and hyperthermia induces pseudo-G1 associated apoptotic cell death in ovarian cancer cells.
5/2012	Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses.
6/2011	Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC).
8/2008	Mitotic arrest-associated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent.
6/2008	Sensitivity to sodium arsenite in human melanoma cells depends upon susceptibility to arsenite-induced mitotic arrest.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Christopher States Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 11/2004
14	Carcinogenesis 01/2022 - 04/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 04/2007
6	Acute Promyelocytic Leukemia 09/2015 - 05/2005
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2018
5	Breast Neoplasms (Breast Cancer) 01/2018 - 07/2004
5	Inflammation (Inflammations) 02/2016 - 11/2009
5	Ovarian Neoplasms (Ovarian Cancer) 06/2014 - 01/2009
5	Atherosclerosis 01/2013 - 04/2007
4	Chromosomal Instability (Chromosome Stability) 01/2022 - 01/2011
4	Non-alcoholic Fatty Liver Disease 12/2018 - 12/2011
4	Liver Diseases (Liver Disease) 01/2013 - 01/2008
3	Obesity 10/2019 - 09/2014
3	Aneuploidy (Aneuploid) 01/2019 - 02/2010
3	Hyperthermia 05/2014 - 06/2011
2	Chronic Disease (Chronic Diseases) 01/2022 - 07/2015
2	Skin Neoplasms (Skin Cancer) 01/2021 - 01/2017
2	Fibrosis (Cirrhosis) 12/2020 - 05/2010
2	Prostatic Neoplasms (Prostate Cancer) 02/2020 - 01/2018
2	Insulin Resistance 12/2018 - 02/2016
2	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2011
2	Fatty Liver 02/2016 - 12/2011
2	Hepatocellular Carcinoma (Hepatoma) 08/2014 - 07/2006
2	Congenital Abnormalities (Deformity) 02/2011 - 09/2007
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2011 - 11/2010
2	Melanoma (Melanoma, Malignant) 08/2008 - 06/2008
1	Ataxia (Dyssynergia) 01/2022
1	Genomic Instability 11/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Hepatitis 12/2020
1	Lung Neoplasms (Lung Cancer) 09/2020
1	Lung Diseases (Lung Disease) 09/2020
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 02/2020
1	Glioma (Gliomas) 02/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2020
1	Myocardial Infarction 12/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2018
1	Nervous System Diseases (Neurological Disorders) 10/2018
1	Kidney Neoplasms (Kidney Cancer) 10/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2016
1	Alcoholic Fatty Liver 02/2016

Drug/Important Bio-Agent (IBA)

30	ArsenicIBA 01/2022 - 05/2005
8	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2014
8	Drinking WaterIBA 01/2022 - 04/2002
8	N-acetyltransferase 1IBA 01/2018 - 07/2004
8	CarcinogensIBA 01/2018 - 07/2004
6	sodium arsenite (sodium metaarsenite)IBA 01/2021 - 06/2008
6	Cisplatin (Platino)FDA LinkGeneric 09/2015 - 01/2009
5	AcetyltransferasesIBA 01/2017 - 01/2007
5	XenobioticsIBA 02/2016 - 09/2007
5	arseniteIBA 02/2010 - 04/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2012
4	Messenger RNA (mRNA)IBA 01/2021 - 07/2006
4	Pharmaceutical PreparationsIBA 01/2018 - 11/2004
4	PlatinumIBA 05/2014 - 01/2009
4	Apolipoproteins E (ApoE)IBA 01/2013 - 04/2007
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2012
3	Small Interfering RNA (siRNA)IBA 01/2018 - 02/2010
3	Polychlorinated Biphenyls (PCBs)IBA 02/2016 - 08/2014
3	aroclor 1260IBA 02/2016 - 08/2014
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2018
2	CadmiumIBA 02/2020 - 10/2019
2	AminesIBA 01/2020 - 07/2007
2	EnzymesIBA 01/2018 - 11/2010
2	CytokinesIBA 02/2016 - 08/2012
2	ApolipoproteinsIBA 01/2012 - 02/2009
2	Arsenic Trioxide (Trisenox)FDA Link 01/2009 - 07/2006
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2022
1	Ataxia Telangiectasia Mutated ProteinsIBA 01/2022
1	SmokeIBA 01/2021
1	CollagenIBA 12/2020
1	X-Linked Inhibitor of Apoptosis ProteinIBA 02/2020
1	2-aminofluoreneIBA 01/2020
1	4-biphenylamineIBA 01/2020
1	MetalsIBA 10/2019
1	human MIRN186 microRNAIBA 01/2019
1	Cacodylic Acid (Cacodylate)IBA 12/2018
1	oxidized low density lipoproteinIBA 12/2018
1	Alanine Transaminase (SGPT)IBA 12/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2018
1	HDL LipoproteinsIBA 12/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2018
1	S-Adenosylmethionine (Ademetionine)IBA 12/2018
1	Estrogen Receptor alphaIBA 12/2018
1	Estrogen ReceptorsIBA 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	Dithiothreitol (Cleland's Reagent)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Dihydrotestosterone (Androstanolone)IBA 01/2018
1	Perilipin-1IBA 01/2018
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2017
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2017
1	Arylamine N-AcetyltransferaseIBA 01/2017
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2016
1	Glucose (Dextrose)FDA LinkGeneric 02/2016
1	LipidsIBA 02/2016

Therapy/Procedure

1	Traditional Medicine (Folk Remedies) 03/2018
1	Therapeutics 01/2018